Author

Amanda Cowton

Observed names: A Cowton, A. Cowton

Observed institutions: University of Siena, University of Bern, Hebrew University of Jerusalem, Hadassah Medical Center, University Hospital of North Durham, Darlington Memorial Hospital, Worthing Hospital, University Hospital of Bern, Royal Shrewsbury Hospital, Renewable Energy Alaska Project, Basildon Hospital, University Hospitals Sussex NHS Foundation Trust, King's College Hospital, Canadian Critical Care Trials Group

OpenAlex ID: A5029131893

Mapping the human genetic architecture of COVID-19

2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 1,008

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 512

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

2020 · Ian Roberts, Haleema Shakur-Still, et al. · The Lancet · 451

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 402

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

2018 · Eva Kirmeier, Lars I Eriksson, et al. · The Lancet Respiratory Medicine · 397

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 361

Whole-genome sequencing reveals host factors underlying critical COVID-19

2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 346

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 303

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

2023 · Alexis Tabah, Niccolò Buetti, et al. · Intensive Care Medicine · 278

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 238

Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study

2016 · Ary Serpa Neto, Carmen S V Barbas, et al. · The Lancet Respiratory Medicine · 217

Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit

2018 · Bertrand Guidet, Hans Flaatten, et al. · Intensive Care Medicine · 193

The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis

2017 · T.E.F. Abbott, T. Ahmad, et al. · British Journal of Anaesthesia · 170

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

2022 · Simin Florescu, Delia Stanciu, et al. · JAMA · 146

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

2022 · Simin Florescu, Delia Stanciu, et al. · JAMA · 143

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141

A second update on mapping the human genetic architecture of COVID-19

2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 135

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

2022 · Simeng Lin, Nicholas A. Kennedy, et al. · Nature Communications · 105

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

2021 · Yaseen M. Arabi, Anthony C. Gordon, et al. · Intensive Care Medicine · 102

Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

2022 · Massimiliano Greco, Thomas De Corte, et al. · Intensive Care Medicine · 81

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial

2023 · Simin Florescu, Delia Stanciu, et al. · JAMA · 68

Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set

2022 · Andrew Conway Morris, Katharina Kohler, et al. · Critical Care · 62

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials

2023 · The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators, Simin Florescu, et al. · JAMA · 59

Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study

2021 · Jakub Fronczek, Kamil Polok, et al. · Critical Care · 52

Works count: 56

Citation count: 7,288

H-index: 34

I10-index: 44